Lung cancer specialist centres NSW

Criteria for a specialist lung cancer centres

A lung resection is surgery to remove of all or part of the lung. It is complex surgery, which requires a team of health care professionals with suitable experience performing this surgery and providing supportive care after surgery.[1]

International studies indicate that patient outcomes can be improved when lung cancer surgery is performed in centres that do a high number of these procedures.[2-6]

It is recommended that specialist lung cancer centres meet the following criteria perform 18 lung resections per year*

* This minimum suggested annual surgical caseload has been selected based on the hospital-level distribution of lung cancer resections in NSW.

Multidisciplinary cancer care team

Patients with lung cancer may have one or more types of treatment, including surgery, chemotherapy, radiotherapy and targeted therapies.

The involvement of a multidisciplinary cancer care team is required.[1] This team brings together health care professionals from different specialties to discuss a patient’s cancer diagnosis and staging, and their treatment options. It also enhances communication and care co-ordination between the specialists involved in a patient’s care.[7]

Australian and international studies show that patients overseen by a multidisciplinary cancer care team experience better outcomes after cancer treatment.[8-10]

Actions for Health Professionals

Actions for Health Professionals

Patient referral

Patients with a suspected or confirmed lung cancer should be referred to a specialist who is a member of a multidisciplinary cancer care team and practices at one of the specialist centres listed below.

Even if surgery does not seem likely at the time of referral, involvement of an appropriate a multidisciplinary team (MDT) early in the cancer journey is recommended to ensure optimal assessment, care, and outcomes.

The Canrefer website allows you to find cancer specialists who are MDT members, and has information about cancer services, optimal care pathways, and patient resources.

Smoking cessation support

Evidence suggests that tobacco cessation following cancer diagnosis improves survival. It also reduces treatment-related complications.[11–13] Health professionals should discuss tobacco use with all patients and provide appropriate cessation support.

List of specialist centres for lung cancer surgery

Local health districtHospital

Annual average lung resection caseload 

Jan 2017 - Dec 2018

Sydney

Royal Prince Alfred Hospital

71 – 100

South Western Sydney

Liverpool Hospital

71 – 100

Northern Sydney

Royal North Shore Hospital

31 – 50

Hunter New England

John Hunter Hospital

31 – 50

Nepean Blue Mountains

Nepean Hospital

31 – 50

South Eastern Sydney

St George Hospital

31 – 50

Western Sydney

Westmead Hospital

21 – 30

  • Surgical caseload data sourced from Admitted Patient, Emergency Department Attendance, and Deaths Register (APEDDR) via Secure Analytics for Population Health Research and Intelligence (SAPHaRI), Centre for Epidemiology and Evidence, NSW Ministry of Health.
  • In-scope diagnoses: C34
  • In-scope procedures: 38438-00, 38438-01, 38438-02, 38440-00, 38440-01, 38441-00, 38441-01.
  • The annual average surgical caseload is based on a two-year average, to account for annual variations in surgical volumes.


List of private specialist centres for lung cancer surgery

Local health districtHospital*Annual average lung resection caseload
Jul 2016 - Jun 2018

Northern Sydney

North Shore Private Hospital

51-70

Northern Sydney

Sydney Adventist Hospital

31-50

Northern Sydney

Macquarie University Hospital

31-50

Southe Eastern Sydney

St George Private Hospital

31- 50

SydneyStrathfield Private Hospital31 - 50

Western Sydney

Westmead Private Hospital

18-30

Hunter New England

Lake Macquarie Private Hospital

18-30

Western Sydney

Norwest Private Hospital

18-30

St Vincent's NetworkSt Vincent's Private Hospital18-30
  • Surgical caseload data sourced from Admitted Patient, Emergency Department Attendance, and Deaths Register (APEDDR) via Secure Analytics for Population Health Research and Intelligence (SAPHaRI), Centre for Epidemiology and Evidence, NSW Ministry of Health.
  • In-scope diagnoses: C34
  • In-scope procedures: 38438-00, 38438-01, 38438-02, 38440-00, 38440-01, 38441-00, 38441-01.
  • The annual average surgical caseload is based on a two-year average, to account for annual variations in surgical volumes.

*Private specialists centres listed have given permission to be included on the Cancer Institute NSW website.

References

  1. Department of Health and Human Services. Optimal care pathway for people with lung cancer. State Government of Victoria, Melbourne. 2014.
  2. Birkmeyer JD, et al. Hospital volume and surgical mortality in the United States. N Engl J Med, 2002. 346(15):1128-37.
  3. Goodney PP, et al. Surgeon speciality and operative mortality with lung resection. Ann Surg, 2005. 241(1):179-84.
  4. Killeen SD, et al. Provider volume and outcomes for oncological procedures. Br J Surg, 2005. 92(4):389-402.
  5. Birkmeyer JD, et al. Hospital volume and late survival after cancer surgery. Ann Surg, 2007. 245(5):777-83.
  6. von Meyenfeldt EM, et al. The relationship between volume or surgeon speciality and outcome in the surgical treatment of lung cancer: a systematic review and meta-analysis. J Thorac Oncol, 2012. 7(7):1170-8.
  7. Boxer MM, et al. Do multidisciplinary team meetings make a difference in the management of lung cancer? Cancer, 2011. 117(22):5112-20.
  8. Wang SM, et al. Effects of multidisciplinary team care on utilization of emergency care for patients with lung cancer. Am J Manag Care, 2014. 20(8):e353-64.
  9. Pan CC, et al. Effects of multidisciplinary team care on the survival of patients with different stages of non-small cell lung cancer: a national cohort study. PLoS One, 2015. 10(5):e0126547.
  10. Ung KA, et al. Impact of the lung oncology multidisciplinary team meetings on the management of patients with cancer. Asia Pac J Clin Oncol, 2016. 12(2):e298-304.
  11. Karam-Hage M, et al. Tobacco use and cessation for cancer survivors: an overview for clinicians. CA Cancer J Clin. 2014. 64(4):272-90.
  12. Warren GW, et al. The biological and clinical effects of smoking by patients with cancer and strategies to implement evidence-based tobacco cessation support. Lancet Oncol. 2014. 15(12):e568-80.
  13. Florou AN, et al. Clinical significance of smoking cessation in subjects with cancer: a 30-year review. Respir Care. 2014. 59(12):1924-36